Image Credit: Cpl Ralph Merry RAF
Photodynamic therapy (PDT) is a form of cancer treatment designed to work by using orally taken photosensitizer drugs that are then triggered by light beams. The light then helps to kill off cancer cells/tumours (skin cancers, types of lung cancers and oesophageal cancers).
However, an interesting side effect that patients have been reporting from the treatment is the ability to see in the dark, or temporary night vision.
In 2015 a team of ”bio-hackers” were able to test the procedure on themselves and ended up being able to see people up to 50 meters away in almost pitch darkness, lasting for a few hours. In 2019, further research was conducted into the possible causality of the unexpected superhero side effect.
As reported by The Debrief Media “The research team behind the study employed complex modelling software that is able to simulate the movement of individual atoms, as well as mimic the formation of chemical bonds at a molecular level. These simulations ran for months before zeroing in on the actual process behind the night vision ability.”
Chemically Induced Night Vision Goggles
It was concluded that a chemical called Chlorin e6 from the treatment method and a naturally occurring protein in the eye called Rhodopsin both interact with each other and work to allow more light into the retina. Hence, the ability to see at night increases tremendously but only lasts until the chemical reaction becomes too weak to alter vision.
This has obviously opened up possibilities for new alternative treatment options for the visually impaired and the possibility for chemically induced night vision goggles to become a thing. But more excitingly, this recent research will allow scientists to take a deeper look into the mechanisms of DNA lesions, which may help to treat a wide range of deadly diseases.